Skip to main content
. 2014 Mar 7;20(9):2255–2266. doi: 10.3748/wjg.v20.i9.2255

Table 2.

Summary of recent chemotherapy trials for locally advanced pancreatic cancer

CHEMO trials Component Median survival P value
GERCORD/GISCAD[66] Gem ± oxaliplatin 9.0 mo vs 7.1 mo 0.13
Van Cutsem et al[67] Gem ± tipifarnib 193 d vs 182 d 0.75
IRINOGEM[68] Gem ± irinotecan 6.3 mo vs 6.6 mo 0.79
Von Hoff et al[69] Gem ± nab-paclitaxel 8.5 mo vs 6.7 mo < 0.001
PRODIGE[70] Gem vs FOLFIRINOX 6.8 mo vs 11.1 mo < 0.001

CHEMO: Chemotherapy; Gem: Gemcitabine.